Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
- Melissa M. Berrien-Elliott
- , Michelle Becker-Hapak
- , Amanda F. Cashen
- , Miriam Jacobs
- , Pamela Wong
- , Mark Foster
- , Ethan McClain
- , Sweta Desai
- , Patrick Pence
- , Sarah Cooley
- , Claudio Brunstein
- , Feng Gao
- , Camille N. Abboud
- , Geoffrey L. Uy
- , Peter Westervelt
- , Meagan A. Jacoby
- , Iskra Pusic
- , Keith E. Stockerl-Goldstein
- , Mark A. Schroeder
- , John F. DiPersio
- Section of Stem Cell Biology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Section of Medical Oncology
- Division of Public Health Sciences
- Division of Oncology
- Bursky Center for Human Immunology and Immunotherapy
- Center of Regenerative Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Immunology
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
104
Link opens in a new tab
Scopus
citations